| Bioactivity | Thalidomide-NH-CH2-CONH-C6-Br is an E3 ligase ligand-linker conjugate that can be used to synthesize DD-03-171 (HY-122830)[1]. |
| Formula | C21H25BrN4O5 |
| Molar Mass | 493.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dennis Dobrovolsky, et al. Bruton’s Tyrosine Kinase Degradation as a Therapeutic Strategy for Cancer. Blood. 2019 Feb 28;133(9):952-961. |
Thalidomide-NH-CH2-CONH-C6-Br
CAS: F: C21H25BrN4O5 W: 493.35
Thalidomide-NH-CH2-CONH-C6-Br is an E3 ligase ligand-linker conjugate that can be used to synthesize DD-03-171 (HY-12283
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.